Searched for
MRNA TECHNOLOGY PLATFORM
To win the deep-tech race, India needs ‘General Innovation Rules’India is launching ambitious science initiatives. However, current financial rules designed for conventional procurement hinder R&D. A new ...- RFK Jr. shocks big pharma, yanks $500 million from mRNA vaccine projects, including for Flu and COVIDUS Health Secretary Robert F. Kennedy Jr. stopped 22 vaccine projects. These projects used mRNA technology. The vaccines aimed to fight COV...
- mRNA vaccine against tuberculosis shows efficacy in mice, results pave way for larger trialsAustralian researchers have developed a new mRNA vaccine for tuberculosis, showing effective results in mice. The vaccine enhances immunity...
- Cipla makes additional investment in German mRNA biotechEthris' has four potential drugs under development pipeline, of which one is for treating uncontrolled asthma and three other for primary c...
- Emcure and its subsidiary Gennova settle legal dispute with HDT Bio over mRNA technologyEmcure Pharmaceuticals and its subsidiary Gennova have resolved all legal disputes with US-based HDT Bio Corp. The parties have entered int...
- Emcure Pharma gets relief in $950-million lawsuitThe US district judge James Robart upheld the Indian drug maker's argument that the court lacked jurisdiction over the company and dismisse...
- CEPI to fund Gennova's self amplifying mRNA vaccine against Disease XThe Coalition for Epidemic Preparedness Innovations (CEPI) and Gennova Biopharmaceuticals have announced a new funding agreement to develop...
- DCGI grants Emergency Use Authorization to Gennova biopharma's Omicron-specific covid boosterThe mRNA-based vaccine was developed by Gennova Biopharmaceuticals using the indigenous platform technology, and supported under the Missio...
- Gennova eyes nod for omicron-specific vaxAs Covid-19 cases saw an uptick in other countries, the government in November approved Bharat Biotech's intranasal vaccine iNCOVACC for he...
- Moderna sues Pfizer/BioNTech for patent infringement over COVID vaccineModerna alleges Pfizer/BioNTech, without permission, copied mRNA technology that Moderna had patented between 2010 and 2016, well before CO...
- Gennova closes in on nod for mRNA vax developed in IndiaGennova had in April submitted interim data on India's first indigenously developed mRNA Covid-19 vaccine to the Central Drug Standard Cont...
- Gennova Biopharmaceuticals developing Omicron specific vaccineGennova Biopharmaceuticals, a subsidiary of Pune-based drugmaker Emcure Pharmaceuticals, is developing a Covid-19 vaccine on its mRNA platf...
- Gennova to finish Phase 2 & 3 trials of its mRNA jab by January 2022The company had submitted the interim Phase-1 clinical trial data to CDSCO, where it tested for safety and immunogenicity.
- Sanofi drops plans for messenger RNA vaccine against virusThe Paris-based company said it will continue to develop another vaccine candidate that is already undergoing late stage human trials. That...
- Chinese firm buys Canada mRNA Covid vaccine tech in $500 million dealWhile almost 1 billion people have been fully vaccinated in China, the country is still lacking an mRNA shot, with most of the population i...
- Pune-based Gennova to use SII's Covishield vaccine as the comparatorTo assess the immunogenicity of the mRNA vaccine, Gennova will have to use Covishield — an existing vaccine — as a comparator, as the regul...
- Indian scientists working on developing mRNA vaccine technology get grantThe team comprises Professor Raghavan Varadarajan, Dr. Mrinmoy De and Dr. SiddharthJhunjhunwala (IISc), and Dr. Amit Awasthi (Translational...
- India's Biological E. to make Providence Therapeutics' mRNA COVID-19 vaccineProvidence will sell up to 30 million doses of its mRNA vaccine, PTX-COVID19-B, to Biological E., and will also provide the necessary techn...
- Vaccine tech transfer hard, next six months key in Covid fight, says leading vaccine makersOn Friday, senior executives from companies such as Moderna, GSK and Bharat Biotech addressed various issues on Covid vaccines, including e...
- HGCO19 vaccine candidate: Gennova starts enrolment for Phase 1/2 human clinical trialsThe DBT said it has approved additional funding towards clinical studies of India's first of its kind' mRNA-based COVID-19 vaccine, HGCO19,...
Load More
